A trio of retina specialists recently reviewed the clinical benefits of aflibercept 8 mg, including its extended dosing intervals, improved patient satisfaction, and enhanced treatment outcomes for various conditions.
Ophthalmology Times Staff Reports
Advertisement
Articles by Ophthalmology Times Staff Reports
Inaugural awards honor 3 residents in ophthalmology, optometry, and retina
The Ophthalmic World Leaders (OWL) Leadership Summit, scheduled for September 21 and 22, 2023, in Austin, Texas, will feature a lineup of prominent speakers and engaging discussions on a wide range of leadership topics and industry insights.
Nominations for the 2023 awards will close July 31, 2023.
The program is dedicated to the education of fellows and residents and offers a unique opportunity to share notable retina research with peers and mentors.
Advertisement
Latest Updated Articles
Visionary in Eye Care Award winners announced at EyeCon 2023Published: December 21st 2023 | Updated:
The 2023 Excellence in Eye Care Resident Recognition Awards honor ophthalmology and optometry residentsPublished: July 17th 2023 | Updated:
COVID-19 pandemic challenges even the best of crisis management plansPublished: May 29th 2020 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
Long-lived Greenland sharks may point to new approaches for retinal disease
3
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
4
IRIS Registry data mined for understanding of pediatric NK
5